Medacta Group Statistics

Total Valuation

Medacta Group has a market cap or net worth of GBP 1.98 billion. The enterprise value is 2.16 billion.

Market Cap	1.98B
Enterprise Value	2.16B

Important Dates

The last earnings date was Sunday, January 19, 2025.

Earnings Date	Jan 19, 2025
Ex-Dividend Date	May 10, 2024

Share Statistics

Current Share Class	n/a
Shares Outstanding	n/a
Shares Change (YoY)	-0.13%
Shares Change (QoQ)	-0.24%
Owned by Insiders (%)	n/a
Owned by Institutions (%)	n/a
Float	6.03M

Valuation Ratios

The trailing PE ratio is 41.50.

PE Ratio	41.50
Forward PE	n/a
PS Ratio	n/a
PB Ratio	n/a
P/TBV Ratio	7.92
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

The stock's EV/EBITDA ratio is 19.02, with an EV/FCF ratio of -1,465.95.

EV / Earnings	45.38
EV / Sales	4.61
EV / EBITDA	19.02
EV / EBIT	32.07
EV / FCF	-1,465.95

Financial Position

The company has a current ratio of 2.20, with a Debt / Equity ratio of 0.67.

Current Ratio	2.20
Quick Ratio	0.73
Debt / Equity	0.67
Debt / EBITDA	1.75
Debt / FCF	-132.68
Interest Coverage	13.20

Financial Efficiency

Return on equity (ROE) is 17.52% and return on invested capital (ROIC) is 9.15%.

Return on Equity (ROE)	17.52%
Return on Assets (ROA)	7.11%
Return on Capital (ROIC)	9.15%
Revenue Per Employee	252,714
Profits Per Employee	26,099
Employee Count	1,730
Asset Turnover	0.79
Inventory Turnover	0.85

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -10.12% in the last 52 weeks. The beta is 1.16, so Medacta Group's price volatility has been higher than the market average.

Beta (5Y)	1.16
52-Week Price Change	-10.12%
50-Day Moving Average	110.88
200-Day Moving Average	119.28
Relative Strength Index (RSI)	49.58
Average Volume (20 Days)	1,090

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, Medacta Group had revenue of GBP 461.46 million and earned 47.66 million in profits. Earnings per share was 2.38.

Revenue	461.46M
Gross Profit	313.46M
Operating Income	66.37M
Pretax Income	56.96M
Net Income	47.66M
EBITDA	106.21M
EBIT	66.37M
Earnings Per Share (EPS)	2.38

Full Income Statement

Balance Sheet

The company has 13.92 million in cash and 195.72 million in debt, giving a net cash position of -181.81 million.

Cash & Cash Equivalents	13.92M
Total Debt	195.72M
Net Cash	-181.81M
Net Cash Per Share	n/a
Equity (Book Value)	291.78M
Book Value Per Share	14.62
Working Capital	168.32M

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was 67.40 million and capital expenditures -68.88 million, giving a free cash flow of -1.48 million.

Operating Cash Flow	67.40M
Capital Expenditures	-68.88M
Free Cash Flow	-1.48M
FCF Per Share	n/a

Full Cash Flow Statement

Margins

Gross margin is 67.93%, with operating and profit margins of 14.38% and 10.33%.

Gross Margin	67.93%
Operating Margin	14.38%
Pretax Margin	12.34%
Profit Margin	10.33%
EBITDA Margin	23.02%
EBIT Margin	14.38%
FCF Margin	n/a

Dividends & Yields

Medacta Group does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	-0.08%
Years of Dividend Growth	n/a
Payout Ratio	20.78%
Buyback Yield	0.13%
Shareholder Yield	0.13%
Earnings Yield	2.41%
FCF Yield	-0.07%

Dividend Details

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

Medacta Group has an Altman Z-Score of 5.92.

Altman Z-Score	5.92
Piotroski F-Score	n/a